Morgan Stanley’s Vivani Medical, Inc. Warrants expiring 03/14/2024 VANIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,140
Closed -$3K 7624
2020
Q4
$3K Hold
13,140
﹤0.01% 6873
2020
Q3
$1K Sell
13,140
-33
-0.3% -$3 ﹤0.01% 6697
2020
Q2
$2K Sell
13,173
-40
-0.3% -$4 ﹤0.01% 6482
2020
Q1
$1K Buy
13,213
+13,179
+38,762% +$10.7K ﹤0.01% 6517
2019
Q4
$0 Hold
34
﹤0.01% 6848
2019
Q3
$0 Hold
34
﹤0.01% 6843
2019
Q2
$0 Sell
34
-21
-38% -$36 ﹤0.01% 6819
2019
Q1
$0 Hold
55
﹤0.01% 6775
2018
Q4
$0 Hold
55
﹤0.01% 6804
2018
Q3
$0 Hold
55
﹤0.01% 6864
2018
Q2
$0 Hold
55
﹤0.01% 6794
2018
Q1
$0 Hold
55
﹤0.01% 6756
2017
Q4
$0 Hold
55
﹤0.01% 6706
2017
Q3
$0 Hold
55
﹤0.01% 6658
2017
Q2
$0 Sell
55
-120
-69% -$357 ﹤0.01% 6689
2017
Q1
$0 Buy
+175
New +$546 ﹤0.01% 6645

Other funds holding VANIW

Morgan Stanley's VANIW Position: Q1 2021 in Review

Morgan Stanley sold out of Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) in Q1 2021, closing a stake of 13,140 shares — an estimated $3K sold.

Morgan Stanley first reported a position in VANIW in Q1 2017 and held it in 16 quarters. The position peaked at $3K in Q4 2020. 5 funds tracked by Wall St. Rank hold VANIW as of Q1 2021.

  • Morgan Stanley reported no remaining Vivani Medical, Inc. Warrants expiring 03/14/2024 position as of Q1 2021 after selling out during the quarter.
  • Morgan Stanley sold 13,140 Vivani Medical, Inc. Warrants expiring 03/14/2024 shares in Q1 2021, an estimated $3K.
  • Morgan Stanley first reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 in Q1 2017 and held it in 16 quarters.
  • Morgan Stanley's Vivani Medical, Inc. Warrants expiring 03/14/2024 position peaked at $3K in Q4 2020.
  • 5 funds tracked by Wall St. Rank held Vivani Medical, Inc. Warrants expiring 03/14/2024 as of Q1 2021.

Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.